UCSD's Moores Cancer Center First in California to Offer Advanced Breast Cancer Treatment
May 21, 2007
SAN DIEGO - The Rebecca and John Moores UCSD Cancer Center is the first facility in California - and the second in the nation - to offer the SAVI™ applicator as part of breast conservation therapy.
full story [PDF - 41Kb]
New Breast Cancer Treatment May Reduce Radiation to Healthy Tissue, Study Shows
May 2, 2007
PHOENIX - A study conducted by Arizona Oncology Services (AOS) shows that the SAVI™ applicator may reduce the amount of radiation delivered to healthy skin during breast cancer treatment. The results were released in a poster presentation at the 2007 American Brachytherapy Society annual meeting in Chicago.
full story [PDF - 29Kb]
Experts Discuss Benefits of New SAVI Breast Cancer Treatment
April 18, 2007
SAN FRANCISCO - Leading experts on breast cancer treatment discussed the use and benefits of the new SAVI™ applicator during a panel discussion held April 12 in San Francisco. The panel took place in conjunction with the 2007 American Society of Breast Disease Annual Symposium.
full story
Arizona Oncology Services Is First to Offer Advanced Breast Cancer Treatment
November 6, 2006
PHOENIX - Arizona Oncology Services announced it is the first medical facility in the nation to treat a patient using the SAVI™ applicator. Robert Kuske, M.D., a leading radiation oncologist, performed the first two cases using the new applicator.
full story [PDF - 21Kb]
BioLucent Introduces New SAVI Breast Brachytherapy Device at ASTRO
October 26, 2006
ALISO VIEJO, Calif. - BioLucent announced the launch of the SAVI™ applicator. The company will introduce the product at the annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO), November 5-9, in Philadelphia. The SAVI device offers a multi-catheter, single-entry approach to breast brachytherapy as part of breast-conserving cancer treatment.
full story
BioLucent Receives FDA Clearance for SAVI, a New Breast Brachytherapy Device
October 24, 2006
ALISO VIEJO, Calif. - BioLucent, Inc. announced that it has received 510(k) clearance from the U. S. Food and Drug Administration for the SAVI™ applicator, a multi-catheter device that provides single-entry breast brachytherapy. SAVI is for use in accelerated partial breast irradiation (APBI) and is designed to provide physicists and radiation oncologists with more treatment planning flexibility.
full story